Medtronic To Report Death Of InFuse User To FDA
Medtronic Inc. is expected to report to the U.S. Food and Drug Administration the death of a woman who underwent a surgery that used the medical company's InFuse spinal graft product,...To view the full article, register now.
Already a subscriber? Click here to view full article